Literature DB >> 15741168

Exocytic trafficking is required for nicotine-induced up-regulation of alpha 4 beta 2 nicotinic acetylcholine receptors.

Tamara Darsow1, T K Booker, Juan Carlos Piña-Crespo, Stephen F Heinemann.   

Abstract

The primary target for nicotine in the brain is the neuronal nicotinic acetylcholine receptor (nAChR). It has been well documented that nAChRs respond to chronic nicotine exposure by up-regulation of receptor numbers, which may underlie some aspects of nicotine addiction. In order to investigate the mechanism of nicotine-induced nAChR up-regulation, we have developed a cell culture system to assess membrane trafficking and nicotine-induced up-regulation of surface-expressed alpha(4)beta(2) nAChRs. Previous reports have implicated stabilization of the nAChRs at the plasma membrane as the potential mechanism of up-regulation. We have found that whereas nicotine exposure results in up-regulation of surface receptors in our system, it does not alter surface receptor internalization from the plasma membrane, postendocytic trafficking, or lysosomal degradation. Instead, we find that transport of nAChRs through the secretory pathway to the plasma membrane is required for nicotine-induced up-regulation of surface receptors. Therefore, nicotine appears to regulate surface receptor levels at a step prior to initial insertion in the plasma membrane rather than by altering their endocytic trafficking or degradation rates as had been previously suggested.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741168     DOI: 10.1074/jbc.M501157200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Mechanisms of inhibition and potentiation of α4β2 nicotinic acetylcholine receptors by members of the Ly6 protein family.

Authors:  Meilin Wu; Clare A Puddifoot; Palmer Taylor; William J Joiner
Journal:  J Biol Chem       Date:  2015-08-14       Impact factor: 5.157

Review 2.  Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Authors:  W E Melroy-Greif; J A Stitzel; M A Ehringer
Journal:  Genes Brain Behav       Date:  2015-12-23       Impact factor: 3.449

3.  The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.

Authors:  Thomas J Gould; George S Portugal; Jessica M André; Matthew P Tadman; Michael J Marks; Justin W Kenney; Emre Yildirim; Michael Adoff
Journal:  Neuropharmacology       Date:  2012-01-21       Impact factor: 5.250

4.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 5.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

Review 6.  Cellular trafficking of nicotinic acetylcholine receptors.

Authors:  Paul A St John
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

7.  The α4 nicotinic receptor promotes CD4+ T-cell proliferation and a helper T-cell immune response.

Authors:  Jacob C Nordman; Pretal Muldoon; Sarah Clark; M Imad Damaj; Nadine Kabbani
Journal:  Mol Pharmacol       Date:  2013-10-09       Impact factor: 4.436

Review 8.  High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness.

Authors:  Alan S Lewis; Marina R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2013-04-28       Impact factor: 4.530

Review 9.  Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors:  Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

Review 10.  Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.

Authors:  Akinori Akaike; Yuki Takada-Takatori; Toshiaki Kume; Yasuhiko Izumi
Journal:  J Mol Neurosci       Date:  2010-01       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.